Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

Evidence supporting secondary prevention strategies.

Publication ,  Journal Article
Blazing, MA; O'Connor, CM
Published in: Curr Opin Cardiol
July 1999

Currently 14 million individuals in the United States have coronary disease. Within the next 2 decades, this number is expected to increase to 21 million persons. To minimize the excessive risk of recurrent cardiac events in these people, evidence-based, cost-effective prevention strategies must be developed. This review highlights the evidence supporting commonly used means of secondary prevention and is divided into two major sections: lifestyle modifications and pharmacologic interventions. Lifestyle changes discussed include smoking cessation, especially newer pharmacologic adjuncts; the efficacy of dietary interventions; and current inroads into the treatment of depression in recurrent events. Pharmacologic innovations include reexamination of a role for warfarin; continued advances in the treatment of hyper- and dyslipidemias, new roles for beta-blockade in congestive heart failure, and finally a view of future measures, risk and targets of risk intervention.

Duke Scholars

Published In

Curr Opin Cardiol

DOI

ISSN

0268-4705

Publication Date

July 1999

Volume

14

Issue

4

Start / End Page

303 / 309

Location

United States

Related Subject Headings

  • Risk Factors
  • Life Style
  • Hypolipidemic Agents
  • Hyperlipidemias
  • Humans
  • Fibrinolytic Agents
  • Estrogen Replacement Therapy
  • Coronary Disease
  • Cardiovascular System & Hematology
  • Antihypertensive Agents
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Blazing, M. A., & O’Connor, C. M. (1999). Evidence supporting secondary prevention strategies. Curr Opin Cardiol, 14(4), 303–309. https://doi.org/10.1097/00001573-199907000-00005
Blazing, M. A., and C. M. O’Connor. “Evidence supporting secondary prevention strategies.Curr Opin Cardiol 14, no. 4 (July 1999): 303–9. https://doi.org/10.1097/00001573-199907000-00005.
Blazing MA, O’Connor CM. Evidence supporting secondary prevention strategies. Curr Opin Cardiol. 1999 Jul;14(4):303–9.
Blazing, M. A., and C. M. O’Connor. “Evidence supporting secondary prevention strategies.Curr Opin Cardiol, vol. 14, no. 4, July 1999, pp. 303–09. Pubmed, doi:10.1097/00001573-199907000-00005.
Blazing MA, O’Connor CM. Evidence supporting secondary prevention strategies. Curr Opin Cardiol. 1999 Jul;14(4):303–309.

Published In

Curr Opin Cardiol

DOI

ISSN

0268-4705

Publication Date

July 1999

Volume

14

Issue

4

Start / End Page

303 / 309

Location

United States

Related Subject Headings

  • Risk Factors
  • Life Style
  • Hypolipidemic Agents
  • Hyperlipidemias
  • Humans
  • Fibrinolytic Agents
  • Estrogen Replacement Therapy
  • Coronary Disease
  • Cardiovascular System & Hematology
  • Antihypertensive Agents